West Pharmaceutical Services, Inc. (WST) is a publicly traded Healthcare sector company. As of September 9, 2026, WST trades at $338.05 with a market cap of $23.93B and a P/E ratio of 42.91. WST moved +0.07% today. Year to date, WST is +22.76%; over the trailing twelve months it is +33.42%. Its 52-week range spans $187.43 to $386.00. Analyst consensus is strong buy with an average price target of $407.38. Rallies surfaces WST's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for WST combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $338.05 |
| Market Cap | $23.93B |
| P/E Ratio | 42.91 |
| EPS | $7.87 |
| Dividend Yield | 0.22% |
| 52-Week High | $386.00 |
| 52-Week Low | $187.43 |
| Volume | 12.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $3.33B |
| Net Income | $564.90M |
| Gross Margin | 36.79% |
9 analysts cover WST: 0 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $407.38.